Stock STRR STAR EQUITY HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Star Equity Holdings, Inc.

Equities

STRR

US85513Q1031

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.8781 USD +1.51% Intraday chart for Star Equity Holdings, Inc. +3.25% -15.97%
Mar. 22 Transcript : Star Equity Holdings, Inc., Q4 2023 Earnings Call, Mar 22, 2024
Mar. 22 Earnings Flash (STRR) STAR EQUITY HOLDINGS Reports Q4 Revenue $14.1M MT

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
  • The company is in a robust financial situation considering its net cash and margin position.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
STAR EQUITY HOLDINGS, INC. Stock Star Equity Holdings, Inc.
-15.97% 13.92M -
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-17.89% 8.36B
B+
RADNET, INC. Stock RadNet, Inc.
+40.49% 3.6B
C+
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-32.64% 2.73B
B-
SYNLAB AG Stock SYNLAB AG
-7.88% 2.47B -
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-7.92% 2.32B
B-
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-14.40% 1.77B
C-
FLEURY S.A. Stock Fleury S.A.
-18.74% 1.55B
A-
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.19% 1.22B
C+
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+5.57% 1.09B
B+
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. STRR Stock
  4. Ratings Star Equity Holdings, Inc.